The 2023 data for European Gross Fixed Capital Formation and Acquisition Less Disposals of Non-Produced Non-Financial Assets in Waste Management in the Manufacture of Basic Pharmaceutical Products and Preparations show Germany leading with 9.7 million euros, followed by France, Italy, and Spain, with Slovenia, Lithuania, and Greece trailing. Year-on-year, Germany and Slovenia showed growth at 3.93% and 3.13%, respectively, whereas France, Italy, and Spain saw declines. Over five years, the compound annual growth rate indicates an overall trend influenced by fluctuations in economic conditions, policy changes, and market demand for pharmaceuticals.
Looking ahead, European countries are expected to increase investment in waste management technologies in the pharmaceutical sector due to regulatory pressures and sustainability goals. Focus on innovation in waste reduction and advanced recycling processes could drive further capital in this area, supporting long-term growth in the sector and aligning with strategic environmental objectives across the EU.
Top countries in Gross Fixed Capital Formation and Acquisition Less Disposals of Non-Produced Non-Financial Assets in Waste Management in Manufacture of Basic Pharmaceutical Products and Pharmaceutical Preparations by the Business Sector by Country
| # | 7 Countries | Million Euros | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 Germany | 9.7 | 2023 | +1.04% | +3.93% | View data |
| 2 | 2 France | 3.8 | 2023 | +2.7% | -1.51% | View data |
| 3 | 3 Italy | 3.6 | 2023 | 0% | -2.57% | View data |
| 4 | 4 Spain | 2.4 | 2023 | 0% | -5.59% | View data |
| 5 | 5 Slovenia | 2.1 | 2023 | +5% | +3.13% | View data |
| 6 | 6 Lithuania | 0.4 | 2023 | 0% | 0% | View data |
| 7 | 7 Greece | 0.2 | 2023 | 0% | 0% | View data |
Latest reports
US Pharmaceuticals Market Report- Q4 2024
In the fourth quarter of 2024, the US pharmaceuticals market exhibited robust growth across various segments, driven by strategic investments, regulatory advancements, and...
Japan Pharmaceuticals Market Report- Q4 2024
The Japanese pharmaceutical industry in Q4 2024 exhibits dynamic shifts driven by government policies, market demand, and strategic innovations. The continuous rise of...
Germany Pharmaceuticals Market Report- Q4 2024
The fourth quarter of 2024 presented a multifaceted landscape for the German pharmaceuticals industry, characterized by economic pressures, regulatory changes, and evolving consumer...
India Pharmaceuticals Market Report- Q4 2024
The Indian pharmaceutical industry in Q4 2024 continues to show dynamic growth, fueled by advancements in biologics and biosimilars, substantial export activities, and...
UK Pharmaceuticals Market Report- Q4 2024
The UK Pharmaceuticals market in Q4 2024 faced a dynamic landscape shaped by economic, regulatory, and competitive factors. Amidst inflationary pressures and evolving...
France Pharmaceuticals Market Report- Q4 2024
The French pharmaceuticals market in the fourth quarter of 2024 was marked by significant developments across various segments, including biopharmaceuticals, generic drugs, over-the-counter...
Canada Pharmaceuticals Market Report- Q4 2024
In the fourth quarter of 2024, the Canadian pharmaceuticals market showcased dynamic growth and adaptation across various segments. The evolving landscape was influenced...
Brazil Pharmaceuticals Market Report- Q4 2024
The Brazil pharmaceuticals market in Q4 2024 is characterized by significant trends and strategic developments across various segments. The demand for generic pharmaceuticals...
Italy Pharmaceuticals Market Report- Q4 2024
The fourth quarter of 2024 presents a dynamic landscape for the pharmaceuticals market in Italy, characterized by significant trends and strategic developments across...
South Korea Pharmaceuticals Market Report- Q1 2025
The first quarter of 2025 has been pivotal for the pharmaceuticals industry in South Korea, marked by significant growth in the biopharmaceuticals and...